Karen L. Bergman

Biography

Ms. Bergman joined FibroGen as Vice President, Investor Relations and Corporate Communications, in 2016. She brings more than 25 years of experience in the pharmaceutical, biotechnology, and medical technology sectors. She has held leadership roles in investor relations, corporate, product, employee and financial communications, and corporate marketing at a number of companies and consultancies. Ms. Bergman, most recently, was the president and co-founder of BCC Partners, LLC, a life sciences and healthcare investor relations and communications strategic advisory firm. Prior, she was Vice President of Corporate Communications and Investor Relations at ALZA Corporation (now Johnson & Johnson), where she supported the company’s transition and success from an R&D company developing products for leading pharmaceutical companies to a commercial organization with marketed products in multiple specialty franchise areas in oncology, urology, endocrinology, neurology and hospital settings. Prior to ALZA, she led the life sciences practice at Burns McClellan Inc. in New York. Ms. Bergman earned her B.A. at Yale University, where she graduated cum laude with distinction.

Research Interest

Finance Management, iotechnology, Pharma, Oncology